A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 5,900 shares of CNTA stock, worth $101,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,900
Previous 12,100 51.24%
Holding current value
$101,244
Previous $109,000 13.76%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.58 - $16.99 $4.71 Million - $9.33 Million
549,242 Added 1434.95%
587,518 $9.39 Million
Q2 2024

Aug 14, 2024

SELL
$8.04 - $11.87 $69,883 - $103,174
-8,692 Reduced 18.51%
38,276 $345,000
Q1 2024

May 15, 2024

SELL
$6.73 - $12.2 $362,316 - $656,799
-53,836 Reduced 53.41%
46,968 $530,000
Q4 2023

Feb 14, 2024

BUY
$5.52 - $8.03 $539,773 - $785,213
97,785 Added 3238.99%
100,804 $802,000
Q3 2023

Nov 14, 2023

SELL
$6.01 - $8.24 $6,526 - $8,948
-1,086 Reduced 26.46%
3,019 $19,000
Q2 2023

Aug 14, 2023

BUY
$3.68 - $6.9 $15,106 - $28,324
4,105 New
4,105 $25,000
Q4 2022

Feb 14, 2023

SELL
$3.05 - $4.19 $466,836 - $641,325
-153,061 Reduced 67.92%
72,307 $224,000
Q3 2022

Nov 14, 2022

SELL
$3.8 - $5.91 $247,817 - $385,420
-65,215 Reduced 22.44%
225,368 $906,000

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.62B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.